Fiduciary Group LLC Abb Vie Inc. Transaction History

Fiduciary Group LLC

  • $971 Million
  • Q3 2024

A detailed history of Fiduciary Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Group LLC holds 24,187 shares of ABBV stock, worth $4.15 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
24,187
Previous 24,168 0.08%
Holding current value
$4.15 Million
Previous $4.15 Million 15.22%
% of portfolio
0.49%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$163.84 - $199.33 $3,112 - $3,787
19 Added 0.08%
24,187 $4.78 Million
Q2 2024

Aug 08, 2024
SELL
$154.79 - $180.76 $44,269 - $51,697
-286 Reduced 1.17%
24,168 $4.15 Million
Q1 2024

May 13, 2024
SELL
$159.82 - $182.1 $38,516 - $43,886
-241 Reduced 0.98%
24,454 $4.45 Million
Q4 2023

Feb 05, 2024
SELL
$137.6 - $154.97 $16,512 - $18,596
-120 Reduced 0.48%
24,695 $3.83 Million
Q3 2023

Nov 13, 2023
SELL
$133.59 - $154.65 $2,538 - $2,938
-19 Reduced 0.08%
24,815 $3.7 Million
Q2 2023

Jul 27, 2023
SELL
$132.51 - $164.9 $31,139 - $38,751
-235 Reduced 0.94%
24,834 $3.35 Million
Q1 2023

May 15, 2023
BUY
$144.61 - $166.54 $96,454 - $111,082
667 Added 2.73%
25,069 $4 Million
Q1 2023

May 15, 2023
SELL
$144.61 - $166.54 $30,368 - $34,973
-210 Reduced 0.84%
24,859 $3.96 Million
Q4 2022

Feb 07, 2023
SELL
$138.31 - $165.87 $12,171 - $14,596
-88 Reduced 0.36%
24,402 $3.95 Million
Q3 2022

Nov 14, 2022
BUY
$134.21 - $153.93 $49,523 - $56,800
369 Added 1.53%
24,490 $3.67 Million
Q2 2022

Aug 12, 2022
BUY
$137.62 - $174.96 $52,570 - $66,834
382 Added 1.61%
24,121 $3.69 Million
Q1 2022

May 13, 2022
SELL
$131.98 - $163.75 $923 - $1,146
-7 Reduced 0.03%
23,739 $3.61 Million
Q4 2021

Feb 14, 2022
SELL
$107.43 - $135.93 $13,106 - $16,583
-122 Reduced 0.51%
23,746 $3.22 Million
Q3 2021

Oct 27, 2021
SELL
$106.4 - $120.78 $113,103 - $128,389
-1,063 Reduced 4.26%
23,868 $2.61 Million
Q2 2021

Aug 05, 2021
BUY
$105.21 - $117.21 $23,251 - $25,903
221 Added 0.89%
24,931 $2.87 Million
Q1 2021

May 03, 2021
BUY
$102.3 - $112.62 $20,460 - $22,524
200 Added 0.82%
24,710 $2.76 Million
Q4 2020

Feb 12, 2021
SELL
$80.49 - $108.67 $68,416 - $92,369
-850 Reduced 3.35%
24,510 $2.54 Million
Q3 2020

Nov 12, 2020
BUY
$85.91 - $100.83 $4,295 - $5,041
50 Added 0.2%
25,360 $2.22 Million
Q2 2020

Aug 14, 2020
SELL
$73.37 - $98.18 $14,674 - $19,636
-200 Reduced 0.78%
25,310 $2.49 Million
Q1 2020

May 11, 2020
SELL
$64.5 - $97.79 $27,541 - $41,756
-427 Reduced 1.65%
25,510 $1.94 Million
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $83,526 - $104,509
-1,158 Reduced 4.27%
25,937 $2.3 Million
Q3 2019

Nov 13, 2019
SELL
$62.98 - $75.72 $678,483 - $815,731
-10,773 Reduced 28.45%
27,095 $2.05 Million
Q2 2019

Aug 05, 2019
SELL
$65.7 - $83.98 $537,360 - $686,872
-8,179 Reduced 17.76%
37,868 $2.75 Million
Q1 2019

May 08, 2019
SELL
$77.14 - $90.79 $74,980 - $88,247
-972 Reduced 2.07%
46,047 $3.71 Million
Q4 2018

Feb 13, 2019
SELL
$77.85 - $96.01 $192,367 - $237,240
-2,471 Reduced 4.99%
47,019 $4.34 Million
Q3 2018

Oct 18, 2018
SELL
$88.91 - $98.84 $519,145 - $577,126
-5,839 Reduced 10.55%
49,490 $4.68 Million
Q2 2018

Aug 02, 2018
SELL
$89.78 - $106.23 $184,318 - $218,090
-2,053 Reduced 3.58%
55,329 $5.13 Million
Q1 2018

May 14, 2018
SELL
$92.01 - $123.21 $129,734 - $173,726
-1,410 Reduced 2.4%
57,382 $5.43 Million
Q4 2017

Feb 02, 2018
SELL
$89.56 - $98.21 $243,244 - $266,738
-2,716 Reduced 4.42%
58,792 $5.69 Million
Q3 2017

Nov 13, 2017
BUY
$69.85 - $89.22 $4.3 Million - $5.49 Million
61,508
61,508 $5.47 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiduciary Group LLC Portfolio

Follow Fiduciary Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email